2023-03-09
Announcement | Esomeprazole magnesium for delayed release oral suspension is officially approved
February 28, 2023, Three doses (10 mg, 20 mg, 40 mg) ofEsomeprazole magnesium for delayed release oral suspension(卫艾宁®), the imported finished product which islicensed fromCipla Ltd. , were formally approved by the NMPA, the National Medical Products Administration. It is approved for the treatment of gastroesophageal reflux disease, eradication of Helicobacter pylori in combi...
More +